Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inmune Bio (INMB) Return on Assets (2019 - 2025)

Inmune Bio (INMB) has disclosed Return on Assets for 7 consecutive years, with 1.44% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 52.0% to 1.44% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.44% through Dec 2025, down 52.0% year-over-year, with the annual reading at 1.32% for FY2025, 43.0% down from the prior year.
  • Return on Assets hit 1.44% in Q4 2025 for Inmune Bio, roughly flat from 1.45% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.28% in Q1 2021 to a low of 1.49% in Q2 2025.
  • Historically, Return on Assets has averaged 0.63% across 5 years, with a median of 0.38% in 2023.
  • Biggest five-year swings in Return on Assets: rose 9bps in 2021 and later tumbled -73bps in 2025.
  • Year by year, Return on Assets stood at 0.28% in 2021, then decreased by -12bps to 0.31% in 2022, then tumbled by -59bps to 0.5% in 2023, then plummeted by -86bps to 0.92% in 2024, then plummeted by -56bps to 1.44% in 2025.
  • Business Quant data shows Return on Assets for INMB at 1.44% in Q4 2025, 1.45% in Q3 2025, and 1.49% in Q2 2025.